Estradiol/levonorgestrel oral - Bayer HealthCare Pharmaceuticals
Alternative Names: E2/LNG continuous oral - Bayer Schering Pharma; E2/LNG pill - Bayer Schering Pharma; Julina; WellnaraLatest Information Update: 02 Oct 2021
At a glance
- Originator Bayer Schering Pharma
- Developer Bayer HealthCare Pharmaceuticals
- Class Estradiol congeners; Estrenes; Hormonal replacements; Norpregnanes; Small molecules
- Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Menopausal syndrome; Postmenopausal osteoporosis
Most Recent Events
- 04 Feb 2019 Chemical structure information added
- 01 Mar 2011 Bayer Schering Pharma is now called Bayer HealthCare Pharmaceuticals
- 16 Apr 2008 Registered for Menopausal syndrome in Japan (PO)